MoneyWorks4Me

The sales declined to Rs. 582.31 millions for the March 2022 quarter as compared to Rs. 655.42 millions during the corresponding quarter last year.Net profit of the cmpany stood at Rs. 47.57 millions for the quarter ended March 2022 a decline of -31.54% from Rs. 69.49 millions  in the same quarter last year.Operating profit for the quarter ended March 2022 decreased to 75.97 millions as compared to 121.44 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 582.31 655.42 -11.15 2196.63 2448.05 -10.27 2196.63 2448.05 -10.27
Other Income 57.02 37.32 52.79 119.93 71.41 67.95 119.93 71.41 67.95
PBIDT 75.97 121.44 -37.44 314.56 449.80 -30.07 314.56 449.80 -30.07
Interest 8.93 1.56 472.44 13.55 2.71 400.00 13.55 2.71 400.00
PBDT 66.93 120.18 -44.31 301.25 447.39 -32.67 301.25 447.39 -32.67
Depreciation 10.12 10.50 -3.62 39.48 40.35 -2.16 39.48 40.35 -2.16
PBT 56.81 109.68 -48.20 261.77 407.04 -35.69 261.77 407.04 -35.69
TAX 9.24 40.19 -77.01 63.86 115.32 -44.62 63.86 115.32 -44.62
Deferred Tax -1.10 1.28 -185.94 1.40 2.31 -39.39 1.40 2.31 -39.39
PAT 47.57 69.49 -31.54 197.91 291.72 -32.16 197.91 291.72 -32.16
Equity 862.45 789.95 9.18 862.45 789.95 9.18 862.45 789.95 9.18
PBIDTM(%) 13.05 18.53 -29.59 14.32 18.37 -22.06 14.32 18.37 -22.06
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..